| Management target | Revenue FY27 |
|---|
| Revenue growth | 8.6% YoY in FY26; 64% HoH growth in H2FY26. |
|---|---|
| Margins | EBITDA margin at 16.39%; PAT margin at 9.86%. |
| Demand visibility | Strong recovery in H2FY26; demand fully restored with 6300+ practitioners. |
| Management confidence | High; management highlights 'delivered as promised' after H1FY26 turnaround. |
Growth
FY26 Revenue reached INR 67 Cr with EBITDA margin improving 42 bps to 16.39%. H2FY26 saw significant 64% HoH sales recovery.
Outlook
Targeting expansion from 18 to 75 clinics by FY27 and 300 clinics long-term. Focusing on high-margin owned brands.
Risks
Historically impacted by demonetization, IL&FS default, COVID-19, and Ukraine war; currently tightening credit terms to manage receivables.
Earnings Call filed with NSE, NSE: AAKAAR. Summary written with AI assistance from the document.
Aakaar Medical Technologies Ltd: key numbers
- Share price
- ₹70.00
- Market cap
- ₹99.21 Cr
- Revenue (annual)
- ₹66.96 Cr
- Net profit (annual)
- ₹6.64 Cr
- P/E (TTM)
- 14.9×Sector 57.8×
- Promoter holding
- 67.05%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aakaar Medical Technologies Ltd
All →Aakaar Medical Technologies Earnings Call: Key Takeaways
Aakaar Medical Technologies reported strong FY26 recovery with ₹66.9cr revenue and record H2 profitability driven by high-margin product launches and improved debtor discipline.
Aakaar Medical Technologies H2 FY26 Results: Net Profit ₹7.4 Cr, Up 32.1% YoY
Aakaar Medical Technologies Ltd reported revenue from operations of ₹41.6 Cr (+22.7% YoY) and net profit of ₹7.4 Cr (+32.1% YoY) for H2 FY26.
- Key figure
- Net profit ₹7.4 Cr · +32.1% YoY
Aakaar Medical Technologies Earnings Call: Key Takeaways
Aakaar Medical Technologies reported H2FY26 revenue of ₹41.6 Cr and PAT of ₹7.4 Cr, successfully pivoting to higher-margin owned brands and cash-first billing.